Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheol-In Kang

Showing results (1-10 of 275) with videos related to

Pageof 28
Sort By:
Infection & Chemotherapy|September 11, 2021
Reply: The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from SputumCheol-In Kang
The Korean Journal of Internal Medicine|December 6, 2013
Persistent methicillin-resistant Staphylococcus aureus bacteremia: do we need a new therapeutic strategy?Cheol-In Kang
Infection & Chemotherapy|November 23, 2013
Antimicrobial resistance in Asia: current epidemiology and clinical implicationsCheol-In Kang, Jae-Hoon Song
Infection Control and Hospital Epidemiology|January 9, 2013
Reply to Su and ChaoCheol-In Kang, Seung Ji Kang
Annals of Hematology|October 22, 2009
ABO discrepancy in a young Korean serviceman with common variable immunodeficiencySeung Hwan Oh, Cheol-In Kang, Juwon Kim, et al.
Medicina (Kaunas, Lithuania)|October 20, 2019
Clinical Significance of Isolates Known to Be Blood Culture Contaminants in Pediatric PatientsSejong Chun, Cheol-In Kang, Yae-Jean Kim, et al.
Annals of Hematology|February 25, 2010
Hematologic malignancy as a risk factor for bacteremic skin and soft tissue infection caused by gram-negative bacilliCheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck, et al.
The American Journal of Emergency Medicine|October 28, 2011
Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the EDCheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2009
Anidulafungin treatment of candidal central nervous system infection in a murine modelCheol-In Kang, Mark S Rouse, Jayawant N Mandrekar, et al.
Annals of Hematology|May 11, 2011
Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancyCheol-In Kang, Doo Ryeon Chung, Kwan Soo Ko, et al.
Pageof 28

Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
Infection & Chemotherapy|September 11, 2021
Reply: The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from SputumCheol-In Kang
The Korean Journal of Internal Medicine|December 6, 2013
Persistent methicillin-resistant Staphylococcus aureus bacteremia: do we need a new therapeutic strategy?Cheol-In Kang
Infection & Chemotherapy|November 23, 2013
Antimicrobial resistance in Asia: current epidemiology and clinical implicationsCheol-In Kang, Jae-Hoon Song
Infection Control and Hospital Epidemiology|January 9, 2013
Reply to Su and ChaoCheol-In Kang, Seung Ji Kang
Annals of Hematology|October 22, 2009
ABO discrepancy in a young Korean serviceman with common variable immunodeficiencySeung Hwan Oh, Cheol-In Kang, Juwon Kim, et al.
Medicina (Kaunas, Lithuania)|October 20, 2019
Clinical Significance of Isolates Known to Be Blood Culture Contaminants in Pediatric PatientsSejong Chun, Cheol-In Kang, Yae-Jean Kim, et al.
Annals of Hematology|February 25, 2010
Hematologic malignancy as a risk factor for bacteremic skin and soft tissue infection caused by gram-negative bacilliCheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck, et al.
The American Journal of Emergency Medicine|October 28, 2011
Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the EDCheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2009
Anidulafungin treatment of candidal central nervous system infection in a murine modelCheol-In Kang, Mark S Rouse, Jayawant N Mandrekar, et al.
Annals of Hematology|May 11, 2011
Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancyCheol-In Kang, Doo Ryeon Chung, Kwan Soo Ko, et al.
Pageof 28